期刊文献+

RNA干扰缺氧诱导因子2对肾癌786-0细胞的影响 被引量:5

Effect of RNA interference on HIF-2 in the renal cancer cell line 786-0
下载PDF
导出
摘要 目的:研究RNA干扰缺氧诱导因子2(HIF-2)对肾癌786-0细胞的影响。方法:合成HIF-2RNAi片段,将RNAi片段定向克隆于RNAi表达载体,测序鉴定;转染人肾癌786-0细胞,RT-PCR、Western印迹法检测HIF-2 RNAi表达载体对HIF-2基因表达的影响,MTT法检测转染HIF-2 RNAi表达载体对细胞生长作用,裸鼠种植肿瘤观察RNA干扰组对肿瘤生长的影响。结果:RNA干扰组HIF-2mRNA的表达受到抑制,明显低于空载体组和对照组HIF-2mRNA的表达(P<0.01),空载体组HIF-2mRNA的表达没有受到影响;RNA干扰组的HIF-2蛋白表达明显降低,明显低于空载体组和对照组(P<0.01),空载体组和对照组HIF-2蛋白的表达无显著差异;RNA干扰组细胞生长减慢,RNA干扰组肿瘤体积和瘤重均小于空白组(P<0.01)。结论:RNA干扰HIF-2可以抑制肾癌786-0细胞HIF-2的表达和抑制细胞生长,减慢裸鼠肿瘤的生长;为肾癌的生物治疗提供一定的实验基础。 AIM: To study the effect of RNA interference on hypoxia- inducible factor-2 (H IF -2) in the renal cell cancer in vitro and in vivo. METHODS: HIF -2 RNAi was synthesized and inserted into RNA interference eukaryotic expression vector which was confirmed by sequencing. The vector was transfected into the renal cancer cell 786 - 0 and positive clone was selected by using G418. The HIF -2 expression was detected by RT -PCR and Western blotting method. The growth of cells was measured by MTT method. Nude mouse xenograft assays were also done. RESULTS: Compared with empty vector group and control group, the amounts of HIF -2 mRNA and protein expression were lower in the HIF -2 RNAi group, the difference was significant (P 〈 0.01 ). No significant difference between empty vector group and control group was observed. The cell growth in the HIF- 2 RNAi group become slower. Compared with control group, the growth of tumor was slower in the RNAi group in the nude mice (P 〈 0.01 ). CONCLUSION: HIF -2 RNAi inhibits the expression of 786 - 0 and cell growth, and slows the growth of tumor in the nude mice. The result provides new application for biological therapy in the renal cell cancer.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第3期509-513,共5页 Chinese Journal of Pathophysiology
关键词 缺氧诱导因子2 肾肿瘤 RNA干扰 Hypoxia - inducible factor - 2 Kidney neoplasms RNA interference
  • 相关文献

参考文献16

  • 1Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 ( EPAS1 ), a transcription factor selectively expressed in endothelial cells [ J]. Genes Dev, 1997,11 (1) :72 -82.
  • 2Ema M, Taya S, Yokotani N, et al. A novel bHLH - PAS factor with close sequence similarity to hypoxia - inducible factor 1 α regulates the VEGF expression and is potentially involved in lung and vascular development[ J]. Proc Natl Aced Sci USA, 1997,94 (9) :4273 - 4278.
  • 3Hogenesch JB, Chan WK, Jackiw VH, et al. Characterization of a subset of the basic - helix - loop - helix - PAS superfarnily that interacts with components of the dioxin signaling pathway[J]. J Biol Chem, 1997,272( 13 ) :8581 - 8593.
  • 4Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer[ J]. Nature, 2001,411 (6835) :342 - 348.
  • 5Maxwell PH, Wiesener MS, Chang GW, et al. The tumor suppressor protein VHL targets hypoxia - inducible factors for oxyen - dependent proteolysis [ J ]. Nature, 1999,399 (6733) :271 - 275.
  • 6Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF - alpha to the yon Hippel - Lindau ubiquitylation complex by O2 -regulated prolyl hydroxylation[ J]. Science,2001, 292(5516) :468 -472.
  • 7Turner KJ, Moore JW, Jones A, et al. Expression of hypoxia- inducible factors in human renal cancer: relationship to angiogenesis and to the yon Hippel - Lindau gene mutation [ J ]. Cancer Res,2002,62 (10) :2957 - 2961.
  • 8Mandriota S J, Turner K J, Davies DR, et al. HIF activation identifies early lesions in VHL kidneys: evidence for site - specific tumor suppressor function in the nephron [J]. Cancer Cell, 2002,1(5) :459 -468.
  • 9Sowter HM, Raval RR, Moore JW, et al. Predominant role of hypoxia - inducible transcription factor (Hif) - 1 alpha versus Hif - 2 alpha in regulation of the transcriptional response to hypoxia [J]. Cancer Res, 2003,63 (19) :6130 -6134.
  • 10Gunaratnam L, Morley M, Franovic A, et al. Hypoxia inducible factor activates the transforming growth factor - alpha/epidermal growth factor receptor growth stimulatory pathway in VHL( -/- ) renal cell carcinoma cells[J]. J Biol Chem, 2003, 278(45):44966-44974.

二级参考文献27

  • 1鞠桂芝,付士波,闫凤琴,李鹏武.DNA损伤诱导细胞周期解偶联[J].吉林大学学报(医学版),2004,30(5):665-667. 被引量:4
  • 2周婷婷,周平,殷莲华.CD73对人乳腺癌细胞侵袭力和运动力的影响[J].中国病理生理杂志,2006,22(2):360-364. 被引量:6
  • 3Noda A,Ning Y,Venable SF,et al.Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen[J].Exp Cell Res,1994,211 (1):90-98.
  • 4Scott MT,Morrice N,Ball KL.Reversible phosphorylation at the C-terminal regulatory domain of p21 (Waf1/Cip1) modulates proliferating cell nuclear antigen binding[J].J Biol Chem,2000,275(15):11529-11537.
  • 5Waldman T,Lengauer C,Kinzler KW,et al.Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21[J].Nature,1996,381(6584):713 -716.
  • 6Bunz F,Dutriaux A,Lengauer C,et al.Requirement for p53 and p21 to sustain G2 arrest after DNA damage[J].Science,1998,282(5393):1497-1501.
  • 7Bi JX,Shuttleworth J,Al-Rubeai M.Uncoupling of cell growth and proliferation results in enhancement of productivity in p21CIP1 -arrested CHO cells[J].Biotechnol Bioeng,2004,85(7):741 -749.
  • 8De Siervi A,Marinissen M,Diggs J,et al.Transcriptional activation of p21 (waf1/cip1) by alkylphospholipids:role of the mitogen-activated protein kinase pathway in the transactivation of the human p21 (waf1/cip1) promoter by Sp1[J].Cancer Res,2004,64(2):743-750.
  • 9Miura Y,Kataoka H,Joh T,et al.Susceptibility to killer T cells of gastric cancer cells enhanced by mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter[J].Microbiol Immunol,2004,48 (2):137-145.
  • 10Crawford DF,Piwnica-Worms H.The G2 DNA damage checkpoint delays expression of genes encoding mitotic regulators[J].J Biol Chem,2001,276(40):37166 -37177.

共引文献8

同被引文献34

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部